Drugmakers ready response as regulator targets brand name extensions
To compile the database, pharma associations such as the Indian Drug Manufacturers Association (IDMA) have asked manufacturers to submit details of their affected product portfolios. The information sought includes brand names, active ingredients, dosage forms, strengths, the likely business impact, and sales data, even for FY26.
Post Comment